Stopping antibiotics after surgical amputation in diabetic foot and ankle infections-A daily practice cohort
- PMID: 31008367
- PMCID: PMC6458464
- DOI: 10.1002/edm2.59
Stopping antibiotics after surgical amputation in diabetic foot and ankle infections-A daily practice cohort
Abstract
Objective: The appropriate duration of antibiotic therapy for diabetic foot infections (DFI) after surgical amputations in toto is debated. There are discrepancies worldwide.
Methods: Using a clinical pathway for adult DFI patients (retrospective cohort analysis), we conducted a cluster-controlled Cox regression analysis. Minimum follow-up was 2 months.
Results: We followed 482 amputated DFI episodes for a median of 2.1 years after the index episode. The DFIs predominately affected the forefoot (n = 433; 90%). We diagnosed osteomyelitis in 239 cases (239/482; 50%). In total, 47 cases (10%) were complicated by bacteremia, 86 (18%) by abscesses and 139 (29%) presented with cellulitis. Surgical amputation involved the toes (n = 155), midfoot (280) and hindfoot (47). Overall, 178 cases (37%) required revascularization. After amputation, the median duration of antibiotic administration was 7 days (interquartile range, 1-16 days). In 109 cases (25%), antibiotics were discontinued immediately after surgery. Overall, clinical failure occurred in 90 DFIs (17%), due to the same pathogens in only 38 cases. In multivariate analysis, neither duration of total postsurgical antibiotic administration (HR 1.0, 95% CI 0.99-1.01) nor immediate postoperative discontinuation altered failure rate (HR 0.9, 0.5-1.5).
Conclusion: According to our clinical pathway, we found no benefit in continuing postsurgical antibiotic administration in routine amputation for DFI. In the absence of residual infection (ie, resection at clear margins), antibiotics should be discontinued.
Keywords: antibiotic duration; diabetic foot infections; failure; osteomyelitis; post‐amputation.
Conflict of interest statement
AR, BK, KG, DL, MAb, PT and DS declare no conflict of interest. IU has received research donations from Innocoll Ltd. for another project. MAs has worked on another investigator‐initiated research project mandated by SwissNoso that was funded by Pfizer USA.
References
-
- Uçkay I, Aragón‐Sánchez J, Lew D, Lipsky BA. Diabetic foot infections: what have we learned in the last 30 years? Int J Infect Dis. 2015;40:81‐91. - PubMed
-
- Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America (IDSA) clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:132‐173. - PubMed
-
- Bernard L, Garzoni C, Uçkay I. Predicting the pathogen of diabetic toe osteomyelitis by two consecutive ulcer cultures with bone contact. Eur J ClinMicrobiol Infect Dis. 2011;30:279‐281. - PubMed
-
- Uçkay I, Agostinho A, Belaieff W, et al. Wound complications in clean surgery: risk factors and association with antibiotic use. World J Surg. 2011;35:973‐980. - PubMed
-
- Dunkel N, Belaieff W, Assal M, et al. Wound dehiscence and stump infection after lower limb amputation: risk factors and association with antibiotic use. J Orthop Sci. 2012;17:588‐594. - PubMed
LinkOut - more resources
Full Text Sources
Medical
